Ecovyst (ECVT) Q2 2026 earnings review
Sales Surge Masks Margin Compression as Calabrian Era Begins
Ecovyst delivered a massive 42% YoY sales surge to $250.0M in Q2 2026, accompanied by a 27% increase in Adjusted EBITDA to $53.1M. However, the top-line explosion is deceiving: $55M of the revenue increase came from passing through higher sulfur costs, which mechanically compressed Adjusted EBITDA margins from 23.8% to 21.2%. The defining event of the quarter was the June 30 closing of the Calabrian acquisition, which transformed the company's product portfolio and prompted management to aggressively raise FY26 guidance across all metrics. While the operational core remains strong, the balance sheet took a hit, with net leverage reversing from its post-divestiture low of 1.2x back up to 2.0x.
🐂 Bull Case
The successful acquisition of the Calabrian sulfur dioxide business immediately diversifies Ecovyst into water treatment and food processing, adding $10-$12M to H2 2026 EBITDA and raising the full-year outlook.
High refinery utilization (driving regeneration services) and escalating mining sector demand (driving virgin sulfuric acid) continue to provide powerful, structural tailwinds to underlying volumes.
🐻 Bear Case
Global sulfur cost spikes are inflating revenue without adding profit. Projected FY26 sulfur pass-through was raised from $155M to $220M, systematically suppressing reported margin percentages.
After divesting the AMC segment to deleverage to 1.2x just six months ago, the $100M term loan for Calabrian has quickly pushed net leverage back up to 2.0x, reducing capital allocation flexibility.
⚖️ Verdict: ⚪
Neutral to slightly Bullish. The core business is executing flawlessly and the Calabrian acquisition is strategically sound, but margin dilution from raw material inflation and a re-leveraged balance sheet warrant close monitoring.
Key Themes
Calabrian Integration Expands Addressable Market
Closed on June 30, the Calabrian acquisition immediately alters Ecovyst's trajectory. As North America's sole on-purpose producer of sulfur dioxide and sodium bisulfite, this asset provides instant access to adjacent, non-cyclical end markets including water treatment, food processing, and pharmaceuticals. Management explicitly baked $10-$12M of H2 EBITDA from this unit into the revised guidance, highlighting rapid financial accretion.
Virgin Sulfuric Acid and Waggaman Compound Growth
Virgin sulfuric acid saw double-digit volume growth, accelerating on the back of positive fundamentals in the mining sector (primarily copper extraction). This structural demand tailwind is being amplified by the May 2025 Waggaman asset acquisition, which is now fully contributing to volume and allowing Ecovyst to optimize its Gulf Coast network.
Refinery Utilization Sustains Regeneration Volumes
The core Ecoservices regeneration business remains highly stable. Favorable alkylate economics and high U.S. refinery utilization rates led to significantly lower customer downtime compared to the prior year. This consistent throughput, combined with favorable contractual repricing, underpins the 27% YoY growth in Adjusted EBITDA.
Sulfur Cost Inflation Distorts Margins
Of the $73.9M YoY sales increase in Q2, roughly $55M was purely the pass-through of record-high sulfur costs. Because these costs are passed through at zero margin, Ecovyst's Adjusted EBITDA margin dropped to 21.2% from 23.8% a year ago. The company had to hike its full-year sulfur pass-through estimate to $220M (from $155M), meaning top-line optics will continue to disconnect from bottom-line reality.
Reversing Leverage Trajectory
Ecovyst's net debt leverage ratio spiked to 2.0x from 1.2x in the prior quarter. This sudden reversal is entirely due to a $100M increase in the term loan to fund the Calabrian acquisition, which added debt without providing trailing twelve-month EBITDA credit. While 2.0x remains within management's historical target range, the rapid releveraging leaves less dry powder for the $146.5M remaining on their share repurchase authorization.
Macro Cautions in Diversified Industrials
Despite raising overall guidance, management deliberately maintained cautious commentary regarding potential softness in specific industrial applications for virgin sulfuric acid. Previous quarters highlighted the nylon market as structurally tepid; a broader industrial slowdown could offset the aggressive growth seen in the mining vertical.
Other KPIs
Accelerating. Up sharply from $11.4 million in 25Q2. This translated to Adjusted Diluted EPS of $0.21, proving that despite margin percentage compression, the core business is generating substantially more absolute profit dollars.
Reversing. Recovered from negative $(2.4) million in H1 2025. Operating cash flow improved to $55.2 million (from $25.3 million), easily covering the $44.8 million in capital expenditures for the half.
Decelerating/Paused. After buying back $35.7 million worth of stock in Q1 2026, the company completely halted repurchases in Q2, likely to preserve cash ahead of the $190 million Calabrian acquisition closing. $146.5 million remains on the authorization.
Guidance
Accelerating. Dramatically raised from prior $890 - $970 million. However, $65 million of this $110 million midpoint raise is strictly due to increased sulfur cost pass-through assumptions (now $220M vs prior $155M).
Accelerating. Raised from the prior $180 - $195 million range. The raise explicitly includes $10 - $12 million of anticipated H2 contribution from the newly integrated Calabrian business.
Accelerating. The lower end of the range was lifted from $40 million to $45 million. This reflects higher expected earnings offsetting a slight $5 million bump to the midpoint of the CapEx forecast ($85 - $95 million).
Accelerating. Upwardly revised from previous $0.50 - $0.65 range, reflecting the flow-through of higher EBITDA from Calabrian and robust base business performance.
Key Questions
Calabrian Synergy Timeline
You've baked $10-$12M of Calabrian EBITDA into H2 2026. How much of this reflects baseline operations versus early realization of the revenue and cost synergies discussed at the time of the deal announcement?
Capital Allocation Priority
With leverage back at 2.0x and zero buybacks in Q2, should investors expect debt paydown to supersede share repurchases for the remainder of 2026?
Industrial Softness
You noted caution regarding softer demand in some industrial applications for virgin sulfuric acid. Are these pockets of weakness primarily concentrated in the nylon end-market, or are you seeing broader macroeconomic cracks in other chemical manufacturing verticals?
Sulfur Price Elasticity
With sulfur pass-through costs climbing to $220M for the year, at what absolute price level do you anticipate these hyper-inflated costs might trigger demand destruction or substitution from your non-refining customers?